H-L-Pyr-OMe

H-L-Pyr-OMe is a protected amino acid ester featuring an L-configured pyrrolidine-derived amino acid residue (Pyr) with the carboxyl group converted to a methyl ester (OMe). The molecule contains a free amino functionality on the pyrrolidine ring and a methyl ester at the former carboxylate position, which changes hydrogen-bonding and reactivity compared with the corresponding free amino acid. H-L-Pyr-OMe is used as an amino acid ester building block in peptide and peptidomimetic synthesis and as a substrate for chemical studies that require controlled carboxyl-group reactivity during stepwise assembly or derivatization.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: CP25860

CAS No:4931-66-2

Synonyms/Alias:4931-66-2;MethylL-pyroglutamate;Methyl(S)-(+)-2-pyrrolidone-5-carboxylate;L-PYROGLUTAMICACIDMETHYLESTER;(S)-Methyl5-oxopyrrolidine-2-carboxylate;Methylpyroglutamate;methyl-5-oxo-l-prolinat;Methyl5-oxo-L-prolinate;methyl(2S)-5-oxopyrrolidine-2-carboxylate;HQGPKMSGXAUKHT-BYPYZUCNSA-N;(S)-(+)-Methyl2-pyrrolidone-5-carboxylate;Methyl5-oxo-2-pyrrolidinecarboxylate#;ZINC03588957;H-Pyr-OMe;PubChem10949;pyroglutamicmethylester;AC1L2VOP;AC1Q5YIL;L-Pyroglutamicacidmethyl;SCHEMBL78947;(S)-5-oxoprolinemethylester;463396_ALDRICH;Proline,5-oxo-,methylester;CTK6I6305;MolPort-000-004-559

Chemical Name:L-Pyroglutamic acid methyl ester

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C6H9NO3
M.W/Mr.
143,14 g/mole

H-L-Pyr-OMe is an amino acid derivative featuring an L-configured pyrrolidine-based amino acid core (H-L-Pyr) capped as a methyl ester (-OMe), yielding a chiral, N-unsubstituted ester suitable for peptide coupling and ester-to-acid conversion strategies. The pyrrolidine ring provides a conformationally constrained, secondary amine environment that can influence side-chain geometry during amide bond formation and downstream cyclization or derivatization. The methyl ester functionality participates in standard carboxylate chemistry for activation and transesterification, while the free amino terminus enables formation of amide-linked intermediates under peptide synthesis conditions. Stereochemical integrity at the L center makes it a practical chiral building block for constructing nitrogen-containing scaffolds and for preparing defined amino acid derivatives used in synthetic and biochemical research.

1. Peptide Synthesis

H-L-Pyr-OMe is used in peptide building-block workflows where an amino acid ester can be incorporated into protected or unprotected coupling sequences to generate defined amide linkages. The L-pyrrolidine stereocenter and the methyl ester provide a handle for controlled C-terminal functional group manipulation, including conversion to the corresponding acid or activation for sequential chain extension. The free amino group enables coupling to activated carboxylic acid partners, supporting synthesis of short peptides, peptide fragments, and constrained peptidomimetic backbones. The resulting ester-to-amide continuity supports downstream elaboration into fully characterized peptide analogs for structure-driven studies and synthetic methodology development.

2. Amino Acid Derivatization

H-L-Pyr-OMe serves as a chiral amino acid ester intermediate for side-chain and backbone derivatization in synthetic organic chemistry. The pyrrolidine ring can undergo functional group transformations that preserve stereochemical information while enabling attachment of substituents for tuning polarity, conformational bias, or hydrogen-bonding patterns. The methyl ester can be selectively hydrolyzed, transesterified, or activated to form new amide or urea linkages, providing a route to diverse carboxylate-derived derivatives. Downstream products derived from this intermediate can be used to prepare libraries of amino acid derivatives for SAR studies, fragment-based lead optimization, and process-oriented intermediate generation.

3. Chiral Synthesis Intermediate

H-L-Pyr-OMe is applied as a chiral amino acid intermediate for stereoselective synthesis of nitrogen-containing scaffolds and peptidomimetic motifs. The L-configuration at the amino acid center enables predictable stereochemical outcomes when the ester is converted to activated carboxyl derivatives or when the amine participates in selective bond-forming steps. The conformational constraint of the pyrrolidine ring supports incorporation into cyclic or semi-cyclic frameworks, which can be relevant for designing constrained peptide analogs and backbone-modified ligands. Chiral retention and functional-group compatibility make this derivative suitable for manufacturing route planning where defined stereochemistry and intermediate stability are required for fine chemical synthesis.

4. Pharmaceutical Intermediate Preparation

H-L-Pyr-OMe can be employed in pharmaceutical intermediate preparation where amino acid-derived fragments are assembled into larger heterocyclic or peptide-like structures. The methyl ester provides a controlled carboxylate equivalent for stepwise synthesis, allowing conversion to acids, activated esters, or coupling-ready carboxyl derivatives during route design. The pyrrolidine amino acid core contributes a nitrogen-rich motif that can support subsequent formation of amide, sulfonamide, or other nitrogen-containing linkages commonly used in medicinal chemistry scaffolds. The compound's stereochemical definition and functional-group reactivity support generation of well-defined intermediates for downstream synthetic elaboration and analytical characterization.

5. Chemical Biology And Labeling

H-L-Pyr-OMe is suitable for chemical biology research requiring amino acid-derived building blocks for probes, tags, and constrained peptide-like constructs. The free amino group and methyl ester functionality enable attachment to electrophiles or coupling partners used to generate labeled fragments, while the pyrrolidine ring can help tune conformational behavior of the resulting conjugates. Ester hydrolysis and re-activation strategies can produce carboxylate forms compatible with bioconjugation chemistries, including formation of stable amide-linked conjugates. Defined stereochemistry at the L center supports reproducible structure-function relationships in assays that depend on precise stereochemical and spatial presentation of functional groups.

Size
1 g;5 g;
InChI
1S/C6H9NO3/c1-10-6(9)4-2-3-5(8)7-4/h4H,2-3H2,1H3,(H,7,8)/t4-/m0/s1
InChI Key
HQGPKMSGXAUKHT-BYPYZUCNSA-N
Canonical SMILES
COC(=O)C1CCC(=O)N1

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Custom Conjugation ServicePeptide CDMOPeptide Modification ServicesEpitope Mapping ServicesPeptide Nucleic Acids SynthesisPeptide Analysis ServicesPeptide Synthesis ServicescGMP Peptide Service
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers